Recombinant TNF alpha (Infliximab Biosimilar) anticorps
-
- Antigène Tous les produits TNF alpha (Infliximab Biosimilar)
- TNF alpha (Infliximab Biosimilar)
- Type d'anticorp
- Recombinant Antibody
- Reactivité
- Humain
-
Hôte
-
Human
-
Clonalité
- Monoclonal
-
Conjugué
- Cet anticorp TNF alpha (Infliximab Biosimilar) est non-conjugé
-
Application
- Flow Cytometry (FACS), In vivo Studies (in vivo), ELISA
- Specificité
- Binds to soluble and transmembrane forms of TNF-alpha and neutralizes its biological activity. Does not bind to TNF-beta.
- Attributs du produit
-
OriginalSpeciesName: Human
OriginalFormat: IgG1
- Purification
- Purified antibody.
- Pureté
- > 98 % as determined by SDS-PAGE
- niveau d'endotoxine
- Endotoxin is < 1.0 EU/mg as determined by the LAL method
- Immunogène
- Purified recombinant human TNF (rTNF).
- Clone
- CA2
- Isotype
- IgG1 kappa
-
-
- Indications d'application
- Optimal working dilution should be determined by the investigator.
- Commentaires
-
NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques.
- Restrictions
- For Research Use only
-
- Buffer
- PBS with 0.02 % Proclin 300.
- Agent conservateur
- ProClin
- Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- 4 °C,-20 °C
- Stockage commentaire
- Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
-
- Antigène
- TNF alpha (Infliximab Biosimilar)
- Abstract
- TNF alpha (Infliximab Biosimilar) Produits
- Synonymes
- anticorps DIF, anticorps TNF-alpha, anticorps TNFA, anticorps TNFSF2, anticorps tumor necrosis factor, anticorps TNF
- Classe de substances
- Biosimilar
- Sujet
- TNF-α, TNFα, TNFSF, Tumor necrosis factor, Cachectin, TNF-alpha, Tumor necrosis factor ligand superfamily member 2, TNF-a, TNFa
- UniProt
- P01375
-